| 摘要 |
The present invention relates to the cytotoxic and radiosensitizing potential of SN-38 (7-ethyl-10-hydroxycamptothecin), a metabolite of CPT-11. SN-38 has been found to be useful for sensitizing hypoxic cells, such as hypoxic cancer cells, to the effects of radiation.
|
